# TAILORx (NCT00310180)

> Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00310180
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: Breast Adenocarcinoma; Hormone Receptor Positive; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIB Breast Cancer AJCC v7
- Interventions: Anastrozole; Exemestane; Laboratory Biomarker Analysis; Letrozole; Quality-of-Life Assessment; Radiation Therapy; Tamoxifen Citrate
- Enrollment: 10273
- Primary outcome: 5-year Disease-free Survival

## Commentary we found

- X threads: 61
- YouTube: 49
- Podcasts: 33
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=tailorx-nct00310180

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00310180", "email": "<work email>"}; the inbox owner confirms by the emailed link.